U.S. Neurovascular Devices Market Size, Share & Industry Analysis, By Device Type (Stenting Systems, Embolization Devices, Neurothrombectomy Devices, and Support Devices), By Application (Cerebral Aneurysms, Ischemic Stroke, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Forecast, 2024-2032

Last Updated: June 30, 2025 | Format: PDF | Report ID: FBI107830

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Epidemiology of Heart Diseases in the U.S.
2. New Product Launches – by Key Market Players
3. Technological Advancements in Neurovascular Devices
4. Key Industry Developments (Partnerships, Mergers, Acquisitions, etc.)
5. Impact of COVID-19 on the Market
U.S. Neurovascular Devices Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Device Type
  1. Stenting Systems
  2. Embolization Devices
  3. Neuothrombectomy Devices
  4. Support Devices
2. Market Analysis, Insights and Forecast – By Application
  1. Cerebral Aneurysms
  2. Ischemic Stroke
  3. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals
  2. Specialty Clinics
  3. Others
Competitive Analysis
1. U.S. Market Share Analysis (2023)
2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
  1. Penumbra, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  2. Stryker
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  3. Johnson and Johnson Services Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  4. MicroPort Scientific Corporation
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  5. Acandis GmbH
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  6. MicroVention Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  7. NeuroVasc Technologies, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  8. Asahi Intecc USA, Inc.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  9. Perflow Medical Ltd.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)